ESC 365 - undefined undefined undefined

Speaker illustration

undefined undefined undefined

Right and left heart functional indices and coupling parameters in the prediction of arrhythmia recurrence among patients with paroxysmal atrial fibrillation

Event: EACVI 2025

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Atrio-ventricular coupling: the new kid on the block to be assessed

How to write a research paper – what the Editor is looking for? (Endorsed by Hellenic Young Cardiologists WG)-Young Panelist (Local Faculty)

Event: ESC Heart & Stroke 2024

Topic: Stroke

Session: Clinical cases and Guidelines

Serum magnesium and phosphorus values are lower among patients with paroxysmal atrial fibrillation: insights from the PLACEBO study

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Pathophysiology and mechanisms of atrial fibrillation

Syncopal patients without prodromes exhibit a diverse pattern of adenosine release during head-up tilt test

Event: ESC Congress 2022

Topic: Noninvasive Diagnostic Methods

Session: Non-invasive diagnostic methods for various arrhythmias

Prevalence of atrial myopathy among hypertrophic cardiomyopathy patients without atrial fibrillation

Event: ESC Congress 2022

Topic: Myocardial Disease

Session: The importance of left atrial assessment with echocardiography

Impact of antidiabetic treatment with dipeptidyl peptidase-4 inhibitors on the risk of cardiac arrhythmias among patients with type 2 diabetes mellitus

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Sodium-glucose co-transporter-2 inhibitors and the risk of major arrhythmias: a meta-analysis of the cardiovascular and renal outcome trials

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure: a meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

ESC 365 is supported by

novartis

Explore sponsored resources